Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study
PLOS Medicine · 05.02.2026 · 23 (2) · e1004920
DOI: 10.1371/journal.pmed.1004920 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, online erschienen am 05.02.2026. Verfasst von Alvaro Schwalb und 5 weiteren Autor:innen. Beteiligte Einrichtung: TB Modelling Group, TB Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Models, Theoretical, Global Health. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE European Research Council.
Abstract (Originalsprache)
Background
Estimating the proportion of individuals currently infected with Mycobacterium tuberculosis ( Mtb ) is key for informing global health policies. Although a substantial portion of the global population exhibit tuberculous immunoreactivity, not all have a viable Mtb infection. Moreover, individuals with recent infections are at a higher risk of developing tuberculosis (TB). Here, we present estimates of the global burden of viable Mtb infection, using new insights into the natural history of TB. Methods and findings We constructed country-specific trends in annual risk of infection considering estimates of TB burden, immunoreactivity reversion, and age-specific mixing. We applied these trends to a deterministic mathematical model incorporating reinfection and self-clearance to estimate recent (within 2 years) and total viable Mtb infections. Empirical data on self-clearance are limited, so rates were informed by modelling estimates. In 2022, we estimated that 133.7 million people (95% uncertainty interval [UI]: 104.0, 171.1) had a recent Mtb infection, representing 1.7% (95% UI: 1.3, 2.2) of the global population. In total, 288.9 million people (95% UI: 242.2, 342.7)—or 3.7% (95% UI: 3.1, 4.3) globally—were estimated to harbour a viable Mtb infection. Among those recently infected, 12.0% (95% UI: 11.4, 12.7) were children under 15 years of age. Most recent infections were found in the World Health Organization regions of South-East Asia (49.0%; 95% UI: 37.2, 62.4), the Western Pacific (19.7%; 95% UI: 12.6, 30.5), and Africa (17.9%; 95% UI: 12.9, 24.1). India, Indonesia, and China had the highest burden, with 39.1 million (95% UI: 18.0, 73.6), 12.0 million (95% UI: 5.8, 22.9), and 11.2 million (95% UI: 5.0, 25.5) people, respectively, recently infected with Mtb . Sensitivity analyses of varying self-clearance scenarios showed significant changes in global estimates of viable Mtb infection, particularly in total burden, with lower self-clearance rates. Overall uncertainty in the estimates was considerable, reflecting limitations in the underlying data informing key model parameters.
Conclusions
Our findings offer global burden estimates of viable Mtb infection and reveal a sizable population recently infected with Mtb and at high risk of progression to disease. New diagnostic tools that can detect individuals with viable Mtb —particularly those who would benefit from TB preventive therapy—are urgently needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- TB Modelling Group, TB Centre, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru.
- School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom.
- Clinical Research Department, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Malawi Liverpool Wellcome Programme, Blantyre, Malawi.
ORCID-Profile: Alvaro Schwalb, Peter J Dodd, Hannah M Rickman, César A Ugarte-Gil, Katherine C Horton, Rein M G J Houben
Förderung
- HORIZON EUROPE European Research Council
Zitieren
APA
Schwalb, A., Dodd, P. J., Rickman, H. M., Ugarte-Gil, C. A., Horton, K. C., & Houben, R. M. G. J. (2026). Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study. PLOS Medicine, 23(2), e1004920. https://doi.org/10.1371/journal.pmed.1004920
Vancouver
Schwalb A, Dodd PJ, Rickman HM, Ugarte-Gil CA, Horton KC, Houben RMGJ. Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study. PLOS Medicine. 2026;23(2):e1004920. doi:10.1371/journal.pmed.1004920
BibTeX
@article{Schwalb2026,
author = {Schwalb, Alvaro and Dodd, Peter J and Rickman, Hannah M and Ugarte-Gil, César A and Horton, Katherine C and Houben, Rein M G J},
title = {Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study},
journal = {PLOS Medicine},
year = {2026},
volume = {23},
number = {2},
pages = {e1004920},
doi = {10.1371/journal.pmed.1004920}
}
EUVIMED